Literature DB >> 21115233

Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival.

T M van Gulik1, J J Kloek, A T Ruys, O R C Busch, G J van Tienhoven, J S Lameris, E A J Rauws, D J Gouma.   

Abstract

BACKGROUND: Effective diagnosis and treatment of patients with hilar cholangiocarcinoma (HCCA) is based on the synergy of endoscopists, interventional radiologists, radiotherapists and surgeons. This report summarizes the multidisciplinary experience in management of HCCA over a period of two decades at the Academic Medical Center in Amsterdam, with emphasis on surgical outcome.
METHODS: From 1988 until 2003, 117 consecutive patients underwent resection on the suspicion of HCCA. Preoperative work-up included staging laparoscopy, preoperative biliary drainage, assessment of volume/function of future remnant liver and radiation therapy to prevent seeding metastases. More aggressive surgical approach combining hilar resection with extended liver resection was applied as of 1998. Outcomes of resection including actuarial 5-year survival were assessed.
RESULTS: Eighteen patients (15.3%) appeared to have a benign lesion on microscopical examination of the specimen, leaving 99 patients with histologically proven HCCA. These 99 patients were analysed according to three 5-year time periods of resection, i.e. period 1 (1988-1993, n=45), 2 (1993-1998, n=25) and 3 (1998-2003, n=29). The rate of R0 resections increased and actuarial five-year survival significantly improved from 20±5% for the periods 1 and 2, to 33±9% in period 3 (p<0.05). Postoperative morbidity and mortality in the last period were 68% and 10%, respectively.
CONCLUSION: Extended surgical resection resulted in increased rate of R0 resections and significantly improved survival. Candidates for resection should be considered by a specialized, multidisciplinary team.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21115233     DOI: 10.1016/j.ejso.2010.11.008

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  35 in total

1.  Metastatic lymph nodes in hilar cholangiocarcinoma: does size matter?

Authors:  Anthony T Ruys; Fiebo J W Ten Kate; Olivier R Busch; Marc R Engelbrecht; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2011-09-26       Impact factor: 3.647

2.  Preoperative computed tomography assessment of skeletal muscle mass is valuable in predicting outcomes following hepatectomy for perihilar cholangiocarcinoma.

Authors:  Robert J S Coelen; Jimme K Wiggers; Chung Y Nio; Marc G Besselink; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2015-02-28       Impact factor: 3.647

3.  In vitro detection of cholangiocarcinoma cells using a fluorescent protein-expressing oncolytic herpes virus.

Authors:  R J S Coelen; M J de Keijzer; R Weijer; V V Loukachov; J K Wiggers; F P J Mul; A C W A van Wijk; Y Fong; M Heger; T M van Gulik
Journal:  Cancer Gene Ther       Date:  2017-04-14       Impact factor: 5.987

4.  Principles of surgical resection in hilar cholangiocarcinoma.

Authors:  Emilio Ramos
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

5.  Delay in surgical treatment of patients with hilar cholangiocarcinoma: does time impact outcomes?

Authors:  Anthony T Ruys; Simon G Heuts; Eric A Rauws; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2013-08-26       Impact factor: 3.647

6.  Improved surgical outcomes for hilar cholangiocarcinoma: changes in surgical procedures and related outcomes based on 40 years of experience at a single institution.

Authors:  Ryota Higuchi; Takehiro Ota; Takehisa Yazawa; Hideki Kajiyama; Tatsuo Araida; Toru Furukawa; Tatsuya Yoshikawa; Ken Takasaki; Masakazu Yamamoto
Journal:  Surg Today       Date:  2015-02-05       Impact factor: 2.549

Review 7.  The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?

Authors:  Neil Bhardwaj; Giuseppe Garcea; Ashley R Dennison; Guy J Maddern
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

8.  Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.

Authors:  Masataka Okuno; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Takashi Mizuno; Junpei Yamaguchi; Masato Nagino
Journal:  J Gastroenterol       Date:  2015-07-18       Impact factor: 7.527

9.  Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage.

Authors:  Jimme K Wiggers; Bas Groot Koerkamp; Robert J Coelen; Erik A Rauws; Mark A Schattner; C Yung Nio; Karen T Brown; Mithat Gonen; Susan van Dieren; Krijn P van Lienden; Peter J Allen; Marc G H Besselink; Olivier R C Busch; Michael I D'Angelica; Robert P DeMatteo; Dirk J Gouma; T Peter Kingham; William R Jarnagin; Thomas M van Gulik
Journal:  Endoscopy       Date:  2015-09-18       Impact factor: 10.093

10.  Hilar cholangiocarcinoma: preoperative liver optimization with multidisciplinary approach. Toward a better outcome.

Authors:  Francesca Ratti; Federica Cipriani; Fabio Ferla; Marco Catena; Michele Paganelli; Luca A M Aldrighetti
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.